Type 1 diabetes trials recruiting in Connecticut

Fewer than 3 recruiting trials found.

All Type 1 diabetes trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
  NCT07061574 · Phase: Phase 1, Phase 2 · Ages: 9 Years to 20 Years · Sex: All (male and female) · Connecticut: New Haven
• Registry for Stage 2 Type 1 Diabetes
  NCT06481904 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Connecticut: New Haven